Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples